Skip to main content
Log in

Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek’s disease viral infections

  • Original Article
  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

Marek’s disease virus (MDV) is a highly cell-associated herpesvirus that causes a disease in chickens characterized by tumor formation and immunosuppression. The changes of major histocompatibility complex (MHC) expression in different MDV-infected cells are not completely understood. In this study, we investigated the expression of the Class I MHC and β2-microglobulin (β2m) genes in response to MDV infection at different time points by real-time PCR. In both in vitro and in vivo, the expression levels of Class I MHC and β2m genes were upregulated during early MDV infections in comparison to control cells; We also found that the expression of Class I MHC gene was downregulated in BudR (5-bromo-2′-deoxyuridine)-treated MSB1 cells at 48 h and MDV-infected chicken embryo fibroblast cells (CEF) at 120 and 168 h post infection (hpi); Furthermore, compared to control groups, Class I MHC and β2m expression levels were downregulated in peripheral blood lymphocytes (PBLC) from MDV-infected chickens at 14 and 28 days post infection (dpi); Interestingly, both Class I MHC and β2m gene expression levels increased again in PBLC from MDV RB1B-infected chickens at 35 dpi, in which MDV was in the latent or transformed infection stages. In addition, Class I MHC expression was clearly decreased in MDV-infected CEF at 120 hpi although β2m expression was significantly increased. These changes in Class I MHC and β2m gene expression might provide more insights into host-virus interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abdul-Careem MF, Hunter BD, Sarson AJ, Parvizi P, Haghighi HR, Read L, Heidari M, Sharif S (2008) Host responses are induced in feathers of chickens infected with Marek’s disease virus. Virology 370:323–332

    Article  PubMed  CAS  Google Scholar 

  • Berrebi A, Bassous L, Haran M, Shtalrid M, Shvidel L (2010) The significance of elevated beta 2-microglobulin (b2-m) in chronic lymphocytic leukemia (CLL): evidence of in vitro secretion following activation of CLL cells. Leuk Res 34:e248–e249

    Article  PubMed  Google Scholar 

  • Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (2005) Structure of the human class I histocompatibility antigen, HLA-A2. J Immunol 174:6–19

    PubMed  CAS  Google Scholar 

  • Calnek BW (2001) Pathogenesis of Marek’s disease virus infection. Curr Top Microbiol Immunol 255:25–55

    Article  PubMed  CAS  Google Scholar 

  • Calvo F, Jabrane N, Faille A, Gauville C, de Cremoux P, Lagier G, Abita JP, Lechat P (1987) Quantitative modifications of major histocompatibility complex (MHC) antigens induced by recombinant gamma interferon in two human breast cancer lines. Int J Immunopharmacol 9:459–468

    Article  PubMed  CAS  Google Scholar 

  • Canovas A, Alonso JJ, Barreiro G, Aguirre C (2010) Prognostic factors in follicular lymphoma: the importance of beta-2 microglobulin. Tumori 96:117–121

    PubMed  Google Scholar 

  • Chang S, Dunn JR, Heidari M, Lee LF, Song J, Ernst CW, Ding Z, Bacon LD, Zhang H (2010) Genetics and vaccine efficacy: host genetic variation affecting Marek’s disease vaccine efficacy in White Leghorn chickens. Poult Sci 89:2083–2091

    Article  PubMed  CAS  Google Scholar 

  • Dalgaard T, Boving MK, Handberg K, Jensen KH, Norup LR, Juul-Madsen HR (2009) MHC expression on spleen lymphocyte subsets in genetically resistant and susceptible chickens infected with Marek’s disease virus. Viral Immunol 22:321–327

    Article  PubMed  CAS  Google Scholar 

  • Ding AH, Lam KM (1986) Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek’s disease tumor cells. Vet Immunol Immunopathol 11:65–72

    Article  PubMed  CAS  Google Scholar 

  • Freeman MR (2007) Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma. J Urol 178:10–11

    Article  PubMed  Google Scholar 

  • Hirai K, Ikuta K, Kitamoto N, Kato S (1981) Latency of herpesvirus of turkey and Marek’s disease virus genomes in a chicken T-lymphoblastoid cell line. J Gen Virol 53:133–143

    Article  PubMed  CAS  Google Scholar 

  • Huang WC, Wu D, Xie Z, Zhau HE, Nomura T, Zayzafoon M, Pohl J, Hsieh CL, Weitzmann MN, Farach-Carson MC, Chung LW (2006) Beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis. Cancer Res 66:9108–9116

    Article  PubMed  CAS  Google Scholar 

  • Hunt HD, Lupiani B, Miller MM, Gimeno I, Lee LF, Parcells MS (2001) Marek’s disease virus down-regulates surface expression of MHC (B Complex) Class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology 282:198–205

    Article  PubMed  CAS  Google Scholar 

  • Ishido S, Wang C, Lee BS, Cohen GB, Jung JU (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–5309

    Article  PubMed  CAS  Google Scholar 

  • Kesson AM, King NJ (2001) Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. J Infect Dis 184:947–954

    Article  PubMed  CAS  Google Scholar 

  • Kim DH, Kim EM, Lee EH, Ji KY, Yi J, Park M, Kim KD, Cho YY, Kang HS (2011) Human papillomavirus 16E6 suppresses major histocompatibility complex class I by upregulating lymphotoxin expression in human cervical cancer cells. Biochem Biophys Res Commun 409:792–798

    Article  PubMed  CAS  Google Scholar 

  • Levy AM, Davidson I, Burgess SC, Dan Heller E (2003) Major histocompatibility complex class I is downregulated in Marek’s disease virus infected chicken embryo fibroblasts and corrected by chicken interferon. Comp Immunol Microbiol Infect Dis 26:189–198

    Article  PubMed  Google Scholar 

  • Lian L, Qu LJ, Zheng JX, Liu CJ, Zhang YP, Chen YM, Xu GY, Yang N (2010) Expression profiles of genes within a subregion of chicken major histocompatibility complex B in spleen after Marek’s disease virus infection. Poult Sci 89:2123–2129

    Article  PubMed  CAS  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408

    Article  PubMed  CAS  Google Scholar 

  • Lobigs M, Mullbacher A, Regner M (2003) MHC class I up-regulation by flaviviruses: immune interaction with unknown advantage to host or pathogen. Immunol Cell Biol 81:217–223

    Article  PubMed  CAS  Google Scholar 

  • Lu Z, Qin A, Qian K, Chen X, Jin W, Zhu Y, Eltahir YM (2010) Proteomic analysis of the host response in the bursa of Fabricius of chickens infected with Marek’s disease virus. Virus Res 153:250–257

    Article  PubMed  CAS  Google Scholar 

  • Means RE, Ishido S, Alvarez X, Jung JU (2002) Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. EMBO J 21:1638–1649

    Article  PubMed  CAS  Google Scholar 

  • Niikura M, Kim T, Hunt HD, Burnside J, Morgan RW, Dodgson JB, Cheng HH (2007) Marek’s disease virus up-regulates major histocompatibility complex class II cell surface expression in infected cells. Virology 359:212–219

    Article  PubMed  CAS  Google Scholar 

  • Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H, Zayzafoon M, Young AN, Marshall FF, Weitzmann MN, Chung LW (2006) Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res 12:7294–7305

    Article  PubMed  CAS  Google Scholar 

  • Nomura T, Huang WC, Seo S, Zhau HE, Mimata H, Chung LW (2007) Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma. J Urol 178:292–300

    Article  PubMed  CAS  Google Scholar 

  • Omar AR, Schat KA (1996) Syngeneic Marek’s disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology 222:87–99

    Article  PubMed  CAS  Google Scholar 

  • Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S (2006) Marek’s disease virus: from miasma to model. Nat Rev Microbiol 4:283–294

    Article  PubMed  CAS  Google Scholar 

  • Plachy J, Pink JR, Hala K (1992) Biology of the chicken MHC (B complex). Crit Rev Immunol 12:47–79

    PubMed  CAS  Google Scholar 

  • Rossi D, Fangazio M, De Paoli L, Puma A, Riccomagno P, Pinto V, Zigrossi P, Ramponi A, Monga G, Gaidano G (2010) Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma. Cancer 116:2188–2200

    PubMed  CAS  Google Scholar 

  • Said A, Azab W, Damiani A, Osterrieder N (2012) Equine herpesvirus type 4 (EHV-4) UL56 and UL49.5 proteins downregulate cell surface MHC class I expression independently of each other. J Virol 86:8059–8071

    Google Scholar 

  • Sarson AJ, Abdul-Careem MF, Read LR, Brisbin JT, Sharif S (2008) Expression of cytotoxicity-associated genes in Marek’s disease virus-infected chickens. Viral Immunol 21:267–272

    Article  PubMed  CAS  Google Scholar 

  • Shi C, Zhu Y, Su Y, Chung LW, Cheng T (2009) Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discov Today 14:25–30

    Article  PubMed  CAS  Google Scholar 

  • Vasireddi M, Hilliard J (2012) Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts. J Virol 86:12503–12511

    Article  PubMed  CAS  Google Scholar 

  • Venugopal K, Payne LN (1995) Molecular pathogenesis of Marek’s disease-recent developments. Avian Pathol 24:597–609

    Article  PubMed  CAS  Google Scholar 

  • Wiertz EJ, Mukherjee S, Ploegh HL (1997) Viruses use stealth technology to escape from the host immune system. Mol Med Today 3:116–123

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by the National Natural Science Foundation of China (31072135, 31272560), Major Basic Research of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 12KJA23001) .

Conflict of interest

All authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aijian Qin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, C., Liu, Q., Qin, A. et al. Expression kinetics of chicken β2-microglobulin and Class I MHC in vitro and in vivo during Marek’s disease viral infections. Vet Res Commun 37, 277–283 (2013). https://doi.org/10.1007/s11259-013-9572-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11259-013-9572-z

Keywords

Navigation